Robert E Hutchison Selected Research

APO protocol 2

1/2005

Advanced-stage large-cell lymphoma in children and adolescents: results of a randomized trial incorporating intermediate-dose methotrexate and high-dose cytarabine in the maintenance phase of the APO regimen: a Pediatric Oncology Group phase III trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert E Hutchison Research Topics

Disease

8	Neoplasms (Cancer) 04/2017 - 05/2003
7	Hodgkin Disease (Hodgkin's Disease) 01/2018 - 01/2012
5	Splenomegaly 01/2022 - 04/2010
3	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2018 - 05/2007
2	Leukocytosis (Pleocytosis) 01/2022 - 04/2010
2	Primary Myelofibrosis (Myelosclerosis) 01/2022 - 04/2010
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2016 - 01/2005
2	Lymphoma (Lymphomas) 03/2015 - 01/2005
2	Polycythemia Vera 04/2012 - 04/2010
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2010 - 01/2002
1	Fever (Fevers) 01/2017
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 10/2016
1	Second Primary Neoplasms (Neoplasms, Second) 10/2016
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2016
1	Breast Neoplasms (Breast Cancer) 02/2013
1	Polycythemia (Erythrocytosis) 09/2012
1	Acute Erythroblastic Leukemia (Erythroleukemia) 04/2012
1	Essential Thrombocythemia 04/2010
1	Thrombocytosis (Thrombocythemia) 04/2010
1	Infections 05/2003
1	Cardiotoxicity 01/2002

Drug/Important Bio-Agent (IBA)

4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 01/2002
3	Phosphotransferases (Kinase)IBA 01/2022 - 04/2012
3	Hemoglobins (Hemoglobin)IBA 09/2012 - 04/2010
2	Anaplastic Lymphoma KinaseIBA 01/2018 - 05/2007
2	DNA (Deoxyribonucleic Acid)IBA 04/2017 - 05/2003
2	Proteins (Proteins, Gene)FDA Link 02/2013 - 01/2012
2	Erythropoietin FDA Link 09/2012 - 04/2010
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 11/2010 - 05/2007
1	ruxolitinibIBA 01/2022
1	Janus Kinase InhibitorsIBA 01/2022
1	CrizotinibIBA 01/2018
1	Immunoglobulin D (IgD)IBA 01/2018
1	Cell-Free Nucleic AcidsIBA 04/2017
1	AlbuminsIBA 01/2017
1	Dexrazoxane (Zinecard)FDA LinkGeneric 10/2016
1	AnthracyclinesIBA 10/2016
1	TOR Serine-Threonine KinasesIBA 03/2015
1	MTOR InhibitorsIBA 03/2015
1	obatoclaxIBA 02/2013
1	Histone Deacetylases (Histone Deacetylase)IBA 04/2012
1	Vorinostat FDA Link 04/2012
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2010
1	Metalloproteases (Metalloproteinases)IBA 05/2007
1	Tyrosine (L-Tyrosine)FDA Link 05/2007
1	SurvivinIBA 05/2007
1	Methotrexate (Mexate)FDA LinkGeneric 01/2005
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2005
1	Vincristine (Oncovin)FDA LinkGeneric 01/2005
1	Prednisone (Sone)FDA LinkGeneric 01/2005
1	Zidovudine (Retrovir)FDA LinkGeneric 05/2003
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 05/2003
1	ParaffinIBA 05/2003
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2002

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 01/2017 - 12/2012
4	Therapeutics 04/2017 - 12/2012
1	Radiotherapy 11/2014
1	Secondary Prevention 01/2012
1	APO protocol 2 01/2005